The stock market performance of Pacific Biosciences of California Inc has been fairly unsteady. Over the last year, the company’s stock hit its highest at $2.72 on 11/07/24, while the lowest price during the same time frame was $0.85, recorded on 05/28/25.
52-week price history of PACB Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Pacific Biosciences of California Inc’s current trading price is -54.41% away from its 52-week high, while its distance from the 52-week low is 45.69%. The stock’s price range during this period has fluctuated between $0.85 and $2.72. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 11.66 million for the day, which was evidently higher than the average daily volume of 9.17 million over the last three months.
Financial Performance and Market Capitalization
Pacific Biosciences of California Inc (PACB) has experienced a quarterly rise of 8.77% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 372.11M and boasts a workforce of 575 employees.
Moving average and trading volume data
PACB Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for PACB stands at 7.63. Similarly, the long-term debt-to-equity ratio is also 7.60.
PACB Stock Price Performance Analysis
The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. This year’s metric has recorded a Price decrease of -8.49%. However, over the past six months, we’ve seen a stronger performance of -36.41%. The price of PACB fallen by 19.23% over the last 30 days. And in the last five days, it has surged by 4.20%.
